News & Updates

Study supports S-ICD for SCD prevention in Brugada syndrome patients

28 Apr 2025 by

Data from a large multicentre registry highlight the potential of a subcutaneous implantable cardioverter defibrillator (S-ICD) as an alternative to transvenous ICD (TV-ICD) for preventing sudden cardiac death (SCD) in patients with Brugada syndrome (BrS).

Study supports S-ICD for SCD prevention in Brugada syndrome patients

28 Apr 2025

Skin pigmentation affects pulse oximeter performance

27 Apr 2025 by

Findings from the EquiOx trial presented at ACC.25 underpin the influence of skin pigmentation in pulse oximetry.

Skin pigmentation affects pulse oximeter performance

27 Apr 2025

4F-PCC bests frozen plasma as factor replacement for cardiac surgery bleeds

26 Apr 2025 by

For physicians requiring coagulation factor replacement to control bleeding after CPB during surgery, 4F-PCC provides superior haemostatic efficacy over frozen plasma, along with some safety advantages, as shown in the FARES-II trial presented at ACC.25

4F-PCC bests frozen plasma as factor replacement for cardiac surgery bleeds

26 Apr 2025

Pecans help enhance diet quality in adults at risk of cardiometabolic diseases

25 Apr 2025 by

Consuming pecans as an alternative to usual snacks may improve lipids/lipoproteins and diet quality in adults at increased risk of cardiometabolic diseases, suggests a study. However, pecan intake does not appear to have any effect on vascular health.

Pecans help enhance diet quality in adults at risk of cardiometabolic diseases

25 Apr 2025

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

24 Apr 2025 by

Significant treatment gaps persist in lipid management among individuals at very high cardiovascular risk, with up to 80 percent of patients not achieving their low-density lipoprotein cholesterol (LDL-C) goals, reports a Singapore study.

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

24 Apr 2025

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Papillary thyroid cancer (PTC) in individuals with arterial hypertension is independently associated with a diagnosis of primary aldosteronism (PA), reports a study.

Primary aldosteronism prevalent in PTC patients with hypertension

24 Apr 2025

Pacemaker implantation after TAVI linked to long-term poor outcomes

24 Apr 2025 by

Pacemaker implantation after transcatheter aortic valve implantation (TAVI) was associated with a significantly worse prognosis in terms of all-cause and cardiovascular (CV) mortality, according to the SwissTAVI trial presented at EHRA 2025.

Pacemaker implantation after TAVI linked to long-term poor outcomes

24 Apr 2025

PWH’s acute HF study supports predischarge initiation of SGLT2i

23 Apr 2025 by

International heart failure (HF) guidelines emphasize early predischarge initiation of all components of guideline-directed medical therapy (GDMT), including sodium-glucose cotransporter 2 inhibitors (SGLT2i), in patients hospitalized for acute HF. In an interview with MIMS Doctor, Dr Guang-Ming Tan of the Division of Cardiology, Chinese University of Hong Kong, discussed positive results of his centre’s recent study that evaluated predischarge initiation of empagliflozin in patients hospitalized for acute new-onset HF regardless of left ventricular ejection fraction (LVEF).

PWH’s acute HF study supports predischarge initiation of SGLT2i

23 Apr 2025

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

23 Apr 2025 by

An 82-year-old frail Chinese male patient with multimorbidity and polypharmacy was admitted to the rehabilitation ward in November 2024 due to prior ischaemic stroke and congestive heart failure (HF) requiring treatment with oxygen and furosemide. Focused cardiac ultrasound (FoCUS) showed a left ventricular ejection fraction (LVEF) of 50 percent, with formal echocardiography being scheduled for late 2025.

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

23 Apr 2025

$Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF$

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

23 Apr 2025 by

The patient was an 80-year-old male with multiple comorbidities, including diabetes mellitus controlled with a sodium-glucose cotransporter-2 inhibitor (SGLT2i), hypertension and coronary artery disease, for which he underwent stenting in October 2023. He also had a pacemaker implanted for heart block. His left ventricular ejection fraction (LVEF) ranged between 40–50 percent. For several years, he had been managed as an outpatient for mild heart failure (HF) symptoms and maintained independence in activities of daily living (ADL).

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

23 Apr 2025

News & Updates

Filter by Specialty:

Specialty:

Study supports S-ICD for SCD prevention in Brugada syndrome patients

Study supports S-ICD for SCD prevention in Brugada syndrome patients

Skin pigmentation affects pulse oximeter performance

Skin pigmentation affects pulse oximeter performance

4F-PCC bests frozen plasma as factor replacement for cardiac surgery bleeds

4F-PCC bests frozen plasma as factor replacement for cardiac surgery bleeds

Pecans help enhance diet quality in adults at risk of cardiometabolic diseases

Pecans help enhance diet quality in adults at risk of cardiometabolic diseases

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

Statin alone ‘insufficient’ in meeting LDL-C targets in patients with IHD

Primary aldosteronism prevalent in PTC patients with hypertension

Primary aldosteronism prevalent in PTC patients with hypertension

Pacemaker implantation after TAVI linked to long-term poor outcomes

Pacemaker implantation after TAVI linked to long-term poor outcomes

PWH’s acute HF study supports predischarge initiation of SGLT2i

PWH’s acute HF study supports predischarge initiation of SGLT2i

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

Use of an SGLT2 inhibitor in an elderly patient with CKM syndrome and polypharmacy

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF

Early initiation of a soluble guanylate cyclase stimulator in an elderly patient with refractory HFrEF